Evidence map›Paper›PMID 36751388›Full record

ArticleCentral-European journal of immunology2022

Autoimmune lymphoproliferative syndrome identified through reverse phenotyping.

Svetlana Kocheva, Marija Gjorgijevska, Marija Vujovic, Kata Martinova, Zorica Antevska-Trajkova, Aleksandra Jovanovska, Katarina Stavrikj, Dijana Plaseska-Karanfilska

Open access · goldAbstract readCase Reports
In one paragraph

Article in Central-European journal of immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Svetlana KochevaFaculty of Medicine, University Clinic for Children's Diseases, Ss. Cyril and Methodius University in Skopje, North Macedonia.
Marija GjorgijevskaResearch Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", MASA, Skopje, North Macedonia.
Marija VujovicResearch Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", MASA, Skopje, North Macedonia.
Kata MartinovaFaculty of Medicine, University Clinic for Children's Diseases, Ss. Cyril and Methodius University in Skopje, North Macedonia.
Zorica Antevska-TrajkovaFaculty of Medicine, University Clinic for Children's Diseases, Ss. Cyril and Methodius University in Skopje, North Macedonia.
Aleksandra JovanovskaFaculty of Medicine, University Clinic for Children's Diseases, Ss. Cyril and Methodius University in Skopje, North Macedonia.
Katarina StavrikjFaculty of Medicine, University Clinic for Children's Diseases, Ss. Cyril and Methodius University in Skopje, North Macedonia.
Dijana Plaseska-KaranfilskaResearch Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", MASA, Skopje, North Macedonia.
Saints Cyril and Methodius University of Skopje · MK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is a chronic non-malignant lymphoproliferative disorder caused by mutations in the genes involved in programmed cell death. It is inherited as an autosomal dominant pattern with variable penetrance. In this paper we present the first report of a Macedonian family with ALPS, caused by a novel heterozygous variant in the FAS gene. The next generation sequencing (NGS) analysis in a patient with splenomegaly, suspected for hereditary spherocytosis, showed presence of the FAS c.913dupA, p.Thr305AsnfsTer16 variant. The same variant was present in the patient's mother, but not in the mother's parents (proband's grandparents). Thus, the pathogenic FAS variant has arisen as a de novo event in the proband's mother. Later, analysis of the newborn affected sister showed presence of the same FAS variant. Additional clinical and laboratory investigations in the proband and her sister confirmed the presence of specific biomarkers for ALPS. A first-line NGS analysis allows identification of the genetic defect and initiation of appropriate clinical examinations to promptly establish the clinical diagnosis in patients with rare diseases. Reverse phenotyping in our case provided a prompt and accurate diagnosis and early initiation of specific therapy.

Indexed as

ALPSnew pathogenic variantreverse phenotyping

Identifiers

PMID36751388
PMCPMC9894091
OpenAlexW4285506494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.